Prokarium is a biotechnology company with a vision to create the best platform for oral delivery of protein vaccines. Our Vaxonella platform makes vaccines more accessible to travellers and people living in rural and resource-poor areas
Latest news
BIA forms Synthetic Biology Working Group – Prokarium is founding member
Excerpt from BIA’s press release today, the 4th April 2013: Eight synthetic biology (synbio) companies have joined the BioIndustry Association (BIA) to form a new group working on this emerging area of bioscience. Synbio is the design and engineering of …
Read More